IsoPlexis is a life sciences company building solutions to accelerate the development of curative medicines and personalized therapeutics. Co.'s single cell proteomics platform, which includes instruments, chip consumables and software, provides an end-to-end solution to reveal a more complete view of protein function at an individual cellular level. Co.'s initial focus has been on developing applications of its platform for cancer immunology and cell and gene therapy. Co.'s platform is an end-to-end solution comprised of its proprietary IsoLight and IsoSpark instruments, IsoCode and CodePlex chip consumables, and IsoSpeak software. We show 2 historical shares outstanding datapoints in our ISO shares outstanding history coverage, used to compute ISO market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ISO market cap history over the course of time is important for investors
interested in comparing ISO's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ISO versus a peer is one thing; comparing
ISO market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ISO can fluctuate over the course of history.
With this page we aim to empower investors researching ISO by allowing them to research the ISO market cap history. |
Free ISO Email Alerts:
Video: The Importance of Market Cap
